App Description

Release MSS5 Clinical Study App. contains content that is new and is tailored for the phase 3 study of Nabiximols Oromucosal Spray entitled:

A Randomized, Double-blind, Placebo-controlled, 2-way Crossover Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Patients with Multiple Sclerosis. The clinical study app. enables study participants to complete daily eDiary entries and view scheduled study appointments during study participation.




GWSP20105 – Study Participant App. The App does not provide medical advice. Please consult with your study doctor with any questions or concerns you may have regarding your individual needs or medical conditions or any related questions about your involvement in the study.

iPhone Screenshots

(click to enlarge)

Release MSS5 screenshot 1 Release MSS5 screenshot 2 Release MSS5 screenshot 3 Release MSS5 screenshot 4 Release MSS5 screenshot 5

App Changes

  • August 05, 2021 Initial release

Other Apps From Parallel 6, Inc.

ABASD Room Finds stay local. Payson Petroleum OfferHubb App Top Tech Awards 6 Appeal Miramar Touch The Pivot Study TAReSA's Care Circle TAReSA Clinical6 Mobile Sanofi ACT14132 Site App Sanofi ACT14132 Patient App My APPLES Study Paratek PTK0796-UUTI-17201 Strata Oncology eStudy Subject App mClinical CCA GepoER Meds POINT 1 Study Site e-Study Lite Otsuka 31-14-204 Telemedicine POINT 1 Study GepoER e-Study Traditional VIR Patient Mobile App RELIEF Study Participant Vedanta-VE800 CHIEF-HF Virtual Study Support Valneva Release MSS1 Release MSS3 KRYSTAL-7 Vaccitech Release SCIS1 MHP-OA Study VLA1553-302 NATiV3 KRYSTAL-12 Release MSS2 Herald Study Triumph Study Vertex MAGNIFY